News
Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of ...
Understanding calcified coronary artery disease, its risk factors, symptoms, diagnosis, treatment, and prevention for a ...
Patients were included if they underwent PCI and stent implantation in the LMCA because of stable CAD or acute coronary syndrome (ie, ST-segment–elevation myocardial infarction [STEMI], non-STEMI, and ...
Cardiac imaging is central to the diagnosis and risk stratification of coronary artery disease, beyond symptoms and clinical risk factors, by providing objective evidence of myocardial ischaemia and ...
Researchers say the data further support the use of an FFR-first strategy in treating intermediate coronary lesions.
Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results